Filed under Healthcare & Social Services

Guyana's health milestone proves PPP investments pay

Henry Singh says WHO's validation of eliminating mother-to-child HIV and syphilis proves PPP/C health spending is working.

Published in Guyana Chronicle⁠

22 November 20262 min / 447 words

Dear Editor,

GUYANA has achieved a historic public-health triumph with the World Health Organization (WHO) officially validating the country’s elimination of mother-to-child transmission of HIV and syphilis as public= health problems.

This landmark recognition for the 2022–2025 period is undeniable proof that the People’s Progressive Party/Civic (PPP/C) government’s strategic investments in healthcare are delivering life-saving results.

Under President, Dr Mohamed Irfaan Ali and Health Minister Dr. Frank Anthony, the aggressive modernisation of hospitals, primary-care centres, diagnostic labs, and workforce training has directly secured healthier futures for Guyanese mothers and newborns.

This kind of thing must be celebrated and, for sure, it engenders great confidence in the administration. It is certainly not a mean feat.

To earn this certification, a country must meet rigorous international benchmarks verified by independent experts. The WHO requires at least 95 percent coverage for antenatal care, HIV and syphilis testing, and timely maternal treatment.

Impact targets also demand keeping new paediatric HIV and congenital syphilis cases below 50 per 100,000 live births, alongside an HIV transmission rate under five percent among breastfeeding populations.

Beyond statistics, Guyana demonstrated robust epidemiological surveillance, high-quality laboratory systems, and strong human rights and gender-equality standards during an intensive Pan American Health Organization (PAHO) assessment.

With dual validation secured, Guyana now stands alongside an elite group of Caribbean and Latin American pioneers. Cuba led the world in 2015, followed by regional neighbours including Antigua and Barbuda, St. Kitts and Nevis, Dominica, Belize, Jamaica, and St. Vincent and the Grenadines.

More recently, The Bahamas and Barbados achieved HIV elimination, while the Turks and Caicos Islands made regional history by adding Hepatitis B elimination to its certification. Guyana’s inclusion in this distinguished cohort highlights its rapid emergence as a regional healthcare leader.

However, this victory is not a plateau; it is a stepping stone towards the WHO’s “triple elimination” initiative, which adds Hepatitis B alongside HIV and syphilis.

Because infants infected with Hepatitis B at birth face severe life-long risks such as liver cancer, triple elimination requires universal maternal screening, antiviral prophylaxis where needed, and administering the Hepatitis B birth-dose vaccine within 24 hours.

To reach this milestone, Guyana must maintain at least 90 percent infant vaccination coverage and reduce Hepatitis B prevalence in children to 0.1 percent or less.

Ahead of the next WHO review in 2030, the foundation laid by the PPP administration has positioned Guyana exceptionally well to sustain these gains and conquer Hepatitis B next. By prioritising preventative medicine and modernising public-health infrastructure, the government has ensured that fewer Guyanese children will suffer from preventable infections.

Every citizen should take pride in Guyana’s dedicated healthcare workers and the decisive leadership making this transformation possible.

Sincerely,Henry Singh